PMID- 22467667 OWN - NLM STAT- MEDLINE DCOM- 20130923 LR - 20161125 IS - 1460-2199 (Electronic) IS - 1047-3211 (Linking) VI - 23 IP - 4 DP - 2013 Apr TI - Phencyclidine-induced decrease of synaptic connectivity via inhibition of BDNF secretion in cultured cortical neurons. PG - 847-58 LID - 10.1093/cercor/bhs074 [doi] AB - Repeated administration of phencyclidine (PCP), a noncompetitive N-methyl-D-aspartate (NMDA) receptor blocker, produces schizophrenia-like behaviors in humans and rodents. Although impairment of synaptic function has been implicated in the effect of PCP, the molecular mechanisms have not yet been elucidated. Considering that brain-derived neurotrophic factor (BDNF) plays an important role in synaptic plasticity, we examined whether exposure to PCP leads to impaired BDNF function in cultured cortical neurons. We found that PCP caused a transient increase in the level of intracellular BDNF within 3 h. Despite the increased intracellular amount of BDNF, activation of Trk receptors and downstream signaling cascades, including MAPK/ERK1/2 and PI3K/Akt pathways, were decreased. The number of synaptic sites and expression of synaptic proteins were decreased 48 h after PCP application without any impact on cell viability. Both electrophysiological and biochemical analyses revealed that PCP diminished glutamatergic neurotransmission. Furthermore, we found that the secretion of BDNF from cortical neurons was suppressed by PCP. We also confirmed that PCP-caused downregulation of Trk signalings and synaptic proteins were restored by exogenous BDNF application. It is possible that impaired secretion of BDNF and subsequent decreases in Trk signaling are responsible for the loss of synaptic connections caused by PCP. FAU - Adachi, Naoki AU - Adachi N AD - Department of Mental Disorder Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo 187-8502, Japan. FAU - Numakawa, Tadahiro AU - Numakawa T FAU - Kumamaru, Emi AU - Kumamaru E FAU - Itami, Chiaki AU - Itami C FAU - Chiba, Shuichi AU - Chiba S FAU - Iijima, Yoshimi AU - Iijima Y FAU - Richards, Misty AU - Richards M FAU - Katoh-Semba, Ritsuko AU - Katoh-Semba R FAU - Kunugi, Hiroshi AU - Kunugi H LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20120330 PL - United States TA - Cereb Cortex JT - Cerebral cortex (New York, N.Y. : 1991) JID - 9110718 RN - 0 (Brain-Derived Neurotrophic Factor) RN - 0 (Excitatory Amino Acid Antagonists) RN - 0 (Nerve Tissue Proteins) RN - 0 (Neurotransmitter Agents) RN - 0 (RNA, Messenger) RN - 0 (Receptors, Glutamate) RN - 0 (Tetrazolium Salts) RN - 0 (Thiazoles) RN - EC 2.7.10.1 (Receptor, trkB) RN - EUY85H477I (thiazolyl blue) RN - J1DOI7UV76 (Phencyclidine) RN - SY7Q814VUP (Calcium) SB - IM MH - Analysis of Variance MH - Animals MH - Animals, Newborn MH - Biophysics MH - Brain-Derived Neurotrophic Factor/genetics/*metabolism MH - Calcium/metabolism MH - Cells, Cultured MH - Cerebral Cortex/*cytology MH - Excitatory Amino Acid Antagonists/*pharmacology MH - Gene Expression Regulation/drug effects MH - Nerve Tissue Proteins/metabolism MH - *Neurons/cytology/drug effects/metabolism MH - Neurotransmitter Agents/metabolism MH - Patch-Clamp Techniques MH - Phencyclidine/*pharmacology MH - RNA, Messenger/metabolism MH - Rats MH - Rats, Wistar MH - Receptor, trkB/metabolism MH - Receptors, Glutamate/genetics/metabolism MH - Signal Transduction/drug effects MH - Synapses/*drug effects MH - Synaptic Potentials/drug effects MH - Tetrazolium Salts/metabolism MH - Thiazoles/metabolism MH - Time Factors EDAT- 2012/04/03 06:00 MHDA- 2013/09/24 06:00 CRDT- 2012/04/03 06:00 PHST- 2012/04/03 06:00 [entrez] PHST- 2012/04/03 06:00 [pubmed] PHST- 2013/09/24 06:00 [medline] AID - bhs074 [pii] AID - 10.1093/cercor/bhs074 [doi] PST - ppublish SO - Cereb Cortex. 2013 Apr;23(4):847-58. doi: 10.1093/cercor/bhs074. Epub 2012 Mar 30.